PS indicates propensity score; n, number of patients; %, number of patients in percent of total per group; M, median; IQR, interquartile range; MI, myocardial infarction; ICU LOS, length of stay on th
aModel has been adjusted for maternal age, parity, and cluster randomisation. In addition to these variables, birth weight has also been adjusted for infant gender and gestational age.bBaseline values
Introduction: Clinical trials and subsequent meta-analyses showed advantages of non-vitamin K antagonists oral anticoagulants (NOACs) over vitamin K antagonists (VKAs) in patients with non-valvular at